BLPH - Bellerophon Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-3.758M

Cash

4.382M

Avg Qtr Burn

-3.085M

Short % of Float

0.89%

Insider Ownership

15.03%

Institutional Own.

8.75%

Qtr Updated

09/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
INOpulse Details Interstitial lung disease, Pulmonary hypertension	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse Details Chronic obstructive pulmonary disease, Pulmonary hypertension, Heart disease, Heart failure	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse Details Sarcoidosis, Pulmonary hypertension	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse® Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.